DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the closing of its previously announced public offering of 22,222,223 shares of its common stock. The Company also announced that the underwriter exercised in full its over-allotment option to purchase an additional 3,333,332 shares, bringing the total shares sold to 25,555,555 at a price of $4.50 per share for gross proceeds of $115 million. Net proceeds were $109 million, after deducting underwriting discounts and estimated offering expenses.
